89 related articles for article (PubMed ID: 8519535)
1. [Energy expenditure of patients with Crohn's disease. Course study during hospitalization].
Dolz C; Raurich JM
Rev Esp Enferm Dig; 1995 Oct; 87(10):702-6. PubMed ID: 8519535
[TBL] [Abstract][Full Text] [Related]
2. [Energy consumption in patients with Crohn's disease. An evolutionary study during hospitalization].
Dolz C; Raurich JM; Ibáñez J; Riera J; Marsé P; Obrador A
Nutr Hosp; 1995; 10(2):81-6. PubMed ID: 7756394
[TBL] [Abstract][Full Text] [Related]
3. [Increase of resting energy expenditure during flare-ups in Crohn disease].
Rigaud D; Cerf M; Angel Alberto L; Sobhani I; Carduner MJ; Mignon M
Gastroenterol Clin Biol; 1993; 17(12):932-7. PubMed ID: 8125226
[TBL] [Abstract][Full Text] [Related]
4. Malabsorption is a major contributor to underweight in Crohn's disease patients in remission.
Vaisman N; Dotan I; Halack A; Niv E
Nutrition; 2006 Sep; 22(9):855-9. PubMed ID: 16928471
[TBL] [Abstract][Full Text] [Related]
5. Impact of disease activity on resting energy expenditure in children with inflammatory bowel disease.
Wiskin AE; Wootton SA; Culliford DJ; Afzal NA; Jackson AA; Beattie RM
Clin Nutr; 2009 Dec; 28(6):652-6. PubMed ID: 19515463
[TBL] [Abstract][Full Text] [Related]
6. Effect of disease localization on the anthropometric and metabolic features of Crohn's disease.
Capristo E; Addolorato G; Mingrone G; Greco AV; Gasbarrini G
Am J Gastroenterol; 1998 Dec; 93(12):2411-9. PubMed ID: 9860401
[TBL] [Abstract][Full Text] [Related]
7. Effect of steroids on energy expenditure and substrate oxidation in women with Crohn's disease.
Al-Jaouni R; Schneider SM; Piche T; Rampal P; Hébuterne X
Am J Gastroenterol; 2002 Nov; 97(11):2843-9. PubMed ID: 12425558
[TBL] [Abstract][Full Text] [Related]
8. Measured versus predicted energy expenditure in children with inactive Crohn's disease.
Hart JW; Bremner AR; Wootton SA; Beattie RM
Clin Nutr; 2005 Dec; 24(6):1047-55. PubMed ID: 16198449
[TBL] [Abstract][Full Text] [Related]
9. [Basal energy expenditure in smokers and non-smokers with Crohn's disease].
Bures J; Horácek J; Davidová M; Král B; Pidrman V
Cas Lek Cesk; 1995 Apr; 134(8):240-2. PubMed ID: 7758081
[TBL] [Abstract][Full Text] [Related]
10. Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease.
Winterkamp S; Weidenhiller M; Otte P; Stolper J; Schwab D; Hahn EG; Raithel M
Am J Gastroenterol; 2002 Dec; 97(12):3071-7. PubMed ID: 12492192
[TBL] [Abstract][Full Text] [Related]
11. Significance of diminished factor XIII in Crohn's disease.
Chamouard P; Grunebaum L; Wiesel ML; Sibilia J; Coumaros G; Wittersheim C; Baumann R; Cazenave JP
Am J Gastroenterol; 1998 Apr; 93(4):610-4. PubMed ID: 9576457
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcome of patients examined by capsule endoscopy for suspected small bowel Crohn's disease.
Girelli CM; Porta P; Malacrida V; Barzaghi F; Rocca F
Dig Liver Dis; 2007 Feb; 39(2):148-54. PubMed ID: 17196893
[TBL] [Abstract][Full Text] [Related]
13. Impact of Disease Activity on Resting Energy Expenditure and Body Composition in Adult Crohn's Disease: A Prospective Longitudinal Assessment.
Gong J; Zuo L; Guo Z; Zhang L; Li Y; Gu L; Zhao J; Cao L; Zhu W; Li N; Li J
JPEN J Parenter Enteral Nutr; 2015 Aug; 39(6):713-8. PubMed ID: 24668997
[TBL] [Abstract][Full Text] [Related]
14. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital.
Bernstein CN; Papineau N; Zajaczkowski J; Rawsthorne P; Okrusko G; Blanchard JF
Am J Gastroenterol; 2000 Mar; 95(3):677-83. PubMed ID: 10710056
[TBL] [Abstract][Full Text] [Related]
15. Malnutrition and impaired muscle strength in patients with Crohn's disease and ulcerative colitis in remission.
Valentini L; Schaper L; Buning C; Hengstermann S; Koernicke T; Tillinger W; Guglielmi FW; Norman K; Buhner S; Ockenga J; Pirlich M; Lochs H
Nutrition; 2008; 24(7-8):694-702. PubMed ID: 18499398
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of surgically treated Crohn's colitis: a prospective study.
Fichera A; McCormack R; Rubin MA; Hurst RD; Michelassi F
Dis Colon Rectum; 2005 May; 48(5):963-9. PubMed ID: 15785882
[TBL] [Abstract][Full Text] [Related]
17. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.
Annese V; Piepoli A; Perri F; Lombardi G; Latiano A; Napolitano G; Corritore G; Vandewalle P; Poulain D; Colombel JF; Andriulli A
Aliment Pharmacol Ther; 2004 Nov; 20(10):1143-52. PubMed ID: 15569117
[TBL] [Abstract][Full Text] [Related]
18. CARD15 in inflammatory bowel disease and Crohn's disease phenotypes: an association study and pooled analysis.
Oostenbrug LE; Nolte IM; Oosterom E; van der Steege G; te Meerman GJ; van Dullemen HM; Drenth JP; de Jong DJ; van der Linde K; Jansen PL; Kleibeuker JH
Dig Liver Dis; 2006 Nov; 38(11):834-45. PubMed ID: 16920047
[TBL] [Abstract][Full Text] [Related]
19. Maintenance of resting energy expenditure after weight loss in premenopausal women: potential benefits of a high-protein, reduced-calorie diet.
Pasiakos SM; Mettel JB; West K; Lofgren IE; Fernandez ML; Koo SI; Rodriguez NR
Metabolism; 2008 Apr; 57(4):458-64. PubMed ID: 18328345
[TBL] [Abstract][Full Text] [Related]
20. Hla-B genotype in Japanese patients with Crohn's disease.
Kinouchi Y; Matsumoto K; Negoro K; Takagi S; Takahashi S; Hiwatashi N; Shimosegawa T
Dis Colon Rectum; 2003 Oct; 46(10 Suppl):S10-4. PubMed ID: 14530653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
